Candriam S.C.A. Dexcom Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Dexcom Inc stock. As of the latest transaction made, Candriam S.C.A. holds 230,451 shares of DXCM stock, worth $17.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

230,451

Previous 115,749 99.1%

Holding current value

$17.6 Million

Previous $13.1 Million 17.69%

% of portfolio

0.09%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $7.34 Million - $13.3 Million	114,702 Added 99.1%	230,451 $15.4 Million
Q2 2024 Aug 05, 2024	SELL	$110.31 - $140.45 $6.42 Million - $8.17 Million	-58,167 Reduced 33.45%	115,749 $13.1 Million
Q1 2024 May 03, 2024	SELL	$114.22 - $140.1 $3.33 Million - $4.09 Million	-29,180 Reduced 14.37%	173,916 $24.1 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $8.78 Million - $14.4 Million	-116,247 Reduced 36.4%	203,096 $25.2 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $21.4 Million - $34.3 Million	248,729 Added 352.24%	319,343 $29.8 Million
Q2 2023 Aug 08, 2023	BUY	$112.47 - $130.98 $1.42 Million - $1.65 Million	12,586 Added 21.69%	70,614 $9.07 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $152,048 - $179,709	1,462 Added 2.58%	58,028 $6.74 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $5.91 Million - $8.53 Million	-69,503 Reduced 55.13%	56,566 $6.41 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $124,450 - $153,513	-1,630 Reduced 1.28%	126,069 $10.2 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $7.05 Million - $13.8 Million	103,667 Added 431.37%	127,699 $9.52 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $302,184 - $418,202	-3,212 Reduced 11.79%	24,032 $12.3 Million
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $2.85 Million - $3.57 Million	21,936 Added 413.26%	27,244 $14.6 Million
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $24,650 - $33,074	-231 Reduced 4.17%	5,308 $2.9 Million
Q2 2021 Jul 20, 2021	SELL	$80.99 - $107.93 $743,974 - $991,444	-9,186 Reduced 62.38%	5,539 $2.37 Million
Q4 2020 Jan 22, 2021	SELL	$78.0 - $104.5 $57,720 - $77,330	-740 Reduced 4.78%	14,725 $5.44 Million
Q3 2020 Oct 19, 2020	SELL	$95.51 - $112.95 $573 - $677	-6 Reduced 0.04%	15,465 $6.38 Million
Q2 2020 Jul 23, 2020	BUY	$62.68 - $105.34 $546,130 - $917,827	8,713 Added 128.93%	15,471 $6.27 Million
Q4 2019 Jan 21, 2020	BUY	$36.62 - $57.29 $31,786 - $49,727	868 Added 14.74%	6,758 $1,000
Q3 2019 Oct 21, 2019	SELL	$35.53 - $43.8 $11,263 - $13,884	-317 Reduced 5.11%	5,890 $1,000
Q2 2019 Aug 01, 2019	BUY	$27.84 - $38.92 $12,360 - $17,280	444 Added 7.7%	6,207 $926,000
Q1 2019 May 02, 2019	BUY	$28.07 - $38.18 $21,754 - $29,589	775 Added 15.54%	5,763 $686,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $134,626 - $186,401	4,988 New	4,988 $598,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account